A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasmsAlessandro Rambaldi, Tiziano Barbui, Guido Finazzi et al.|British Journal of Haematology|2010Cited by 242